SPET in psychopharmacology

Area of Science:

• Neuroscience
• Pharmacology
• Medical Imaging

Background:

• Positron emission tomography (PET) and single photon emission tomography (SPET) enable in vivo human biological process assessment.
• Research has predominantly focused on PET, yielding significant findings in central nervous system (CNS) diseases.
• SPET, despite limitations, has proven feasible and useful for research.

Purpose of the Study:

• To review the advantages, limitations, and results of SPET in psychopharmacology.
• To highlight SPET's utility in biological psychiatry and psychoactive drug development.
• To provide a comprehensive overview of SPET applications in psychiatric research.

Main Methods:

• Literature review of studies utilizing SPET in psychopharmacology.
• Analysis of SPET's technical capabilities, including quantification and kinetic modeling.
• Evaluation of tracer validation methods in SPET research.

Main Results:

• SPET demonstrates feasibility for in vivo assessment in psychiatric research.
• Methodological limitations of SPET have been identified and addressed.
• SPET offers valuable data for understanding biological psychiatry and drug effects.

Conclusions:

• SPET is a valuable tool in psychopharmacology, complementing PET research.
• Further research can leverage SPET's capabilities for advancements in CNS disease understanding and drug development.
• The review underscores the demonstrated feasibility and utility of SPET in psychiatric research.